These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 34185714)

  • 1. Pediatric liquid 'single tablet regimens' for HIV-a call to action.
    Winslow DL
    AIDS; 2021 Jul; 35(9):1497-1498. PubMed ID: 34185714
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of adherence to generic multi-tablet regimens vs. brand multi-tablet and brand single-tablet regimens likely to incorporate generic antiretroviral drugs by breaking or not fixed-dose combinations in HIV-infected patients.
    Rwagitinywa J; Lapeyre-Mestre M; Bourrel R; Montastruc JL; Sommet A
    Fundam Clin Pharmacol; 2018 Aug; 32(4):450-458. PubMed ID: 29505661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV Clinical Updates: New Single-Tablet Regimens.
    Sebaaly JC; Kelley D
    Ann Pharmacother; 2019 Jan; 53(1):82-94. PubMed ID: 30073873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-tablet, Single-Tablet, or Long-Acting Antiretroviral Treatment for HIV: A Cross-sectional Study of Patient Preferences in the United States and Spain.
    Carracedo AS; Oliveira V; Saz J; Pujol F; Milinkovic A; Webel A
    J Assoc Nurses AIDS Care; 2022 Nov-Dec 01; 33(6):638-645. PubMed ID: 35878049
    [No Abstract]   [Full Text] [Related]  

  • 5. Expanding options of child-friendly, single-tablet regimens for young children with HIV.
    Cressey TR; Turkova A
    Lancet HIV; 2024 May; 11(5):e275-e276. PubMed ID: 38621390
    [No Abstract]   [Full Text] [Related]  

  • 6. Single-tablet regimens in HIV: does it really make a difference?
    Aldir I; Horta A; Serrado M
    Curr Med Res Opin; 2014 Jan; 30(1):89-97. PubMed ID: 24040862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The making of the one pill-Developing single tablet regimens for HIV and for HCV.
    Yang T; Oliyai R; Kent KM
    Antivir Ther; 2022 Apr; 27(2):13596535211067606. PubMed ID: 35491563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Less is more: A novel single-tablet regimen with two-drugs, dolutegravir/lamivudine.
    Sun J; Lu H
    Drug Discov Ther; 2021 Sep; 15(4):225-226. PubMed ID: 34334555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elvitegravir-Cobicistat-Emtricitabine-Tenofovir Alafenamide Single-tablet Regimen for Human Immunodeficiency Virus Postexposure Prophylaxis.
    Gantner P; Hessamfar M; Souala MF; Valin N; Simon A; Ajana F; Bouvet E; Rouveix E; Cotte L; Bani-Sadr F; Hustache-Mathieu L; Lebrette MG; Truchetet F; Galempoix JM; Piroth L; Pellissier G; Muret P; Rey D;
    Clin Infect Dis; 2020 Feb; 70(5):943-946. PubMed ID: 31804669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The transformation of HIV therapy: One pill once a day.
    Choudhary MC; Mellors JW
    Antivir Ther; 2022 Apr; 27(2):13596535211062396. PubMed ID: 35492017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pilot comparison of the ease of swallowing of single tablet antiretroviral regimens.
    Parraga Acosta T; Osborn Z; Lee JC; Haubrich RH; McNicholl I; McKinnon JE
    AIDS Care; 2022 Mar; 34(3):404-407. PubMed ID: 34125632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiretroviral pill count and clinical outcomes in treatment-naïve patients with HIV infection.
    Young J; Smith C; Teira R; Reiss P; Jarrín Vera I; Crane H; Miro JM; D'Arminio Monforte A; Saag M; Zangerle R; Bucher HC;
    HIV Med; 2018 Feb; 19(2):132-142. PubMed ID: 29110395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single tablet HIV regimens facilitate virologic suppression and retention in care among treatment naïve patients.
    Hemmige V; Flash CA; Carter J; Giordano TP; Zerai T
    AIDS Care; 2018 Aug; 30(8):1017-1024. PubMed ID: 29478329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate single-tablet regimen (Stribild®): a review of its use in the management of HIV-1 infection in adults.
    Perry CM
    Drugs; 2014 Jan; 74(1):75-97. PubMed ID: 24338165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FDA approves four-drug anti-HIV combination tablet.
    Traynor K
    Am J Health Syst Pharm; 2012 Oct; 69(19):1616. PubMed ID: 22997108
    [No Abstract]   [Full Text] [Related]  

  • 16. Adherence after treatment switch from a multiple tablet antiretroviral regimen to a single tablet antiretroviral regimen.
    Sutton SS; Magagnoli J; H Cummings T; Hardin JW
    Therapie; 2021; 76(6):567-576. PubMed ID: 33589316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV update: Which single-tablet regimens, and when.
    Kirchner JT
    J Fam Pract; 2016 Nov; 65(11):762-768. PubMed ID: 28087863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of three galenic forms of lamivudine in young West African children living with Human Immunodeficiency Virus.
    Pressiat C; Dainguy E; Tréluyer JM; Yonaba C; Urien S; Eboua F; Foissac F; Dahourou DL; Bouazza N; Malateste K; Desmonde S; Pruvost A; Leroy V; Hirt D; Study Group TMA
    Antivir Ther; 2021 Nov; 26(6-8):134-140. PubMed ID: 35485334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triple-drug tablet approved for HIV infection.
    Thompson CA
    Am J Health Syst Pharm; 2001 Jan; 58(1):22. PubMed ID: 11194130
    [No Abstract]   [Full Text] [Related]  

  • 20. Safety and efficacy of coformulated efavirenz/emtricitabine/tenofovir single-tablet regimen in treatment-naive patients infected with HIV-1.
    Gallien S; Flandre P; Nguyen N; De Castro N; Molina JM; Delaugerre C
    J Med Virol; 2015 Feb; 87(2):187-91. PubMed ID: 25070158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.